Skip to search formSkip to main contentSkip to account menu

MK-208

Known as: MK 208, MK208 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Famotidine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Characterization of central H2 receptors mediating cardiovascular activity by means of three histamine H2 receptor antagonists: MK‐208, BMY‐25368, and cimetidine in the rat
Stimulation of central histamine H1 and or H2 receptors with histaminergic drugs results in a dose‐related pressor response and… 
1985
1985
Famotidine (MK-208) in the treatment of gastric ulcer. Results of a multicenter double-blind controlled study.
The aim of the present investigation was to study the efficacy and safety of famotidine (MK-208), a new, potent, histamine H2… 
1985
1985
MK-208, a novel histamine H2-receptor inhibitor with prolonged antisecretory effect
MK-208 is a guanidinothiazole derivative reported to be a potent H2 blocker devoid of antiandrogenic activity. Its potency and… 
1985
1985
Effects of hormones (calcitonin, GIP) and pharmacological antagonists (ranitidine and famotidine) on isolated rat parietal cells
1984
1984
Studies on the H2-receptor antagonism of MK-208 in isolated rabbit gastric glands.
1983
1983
Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
MK-208 [3-(((2-(aminoiminomethyl)amino)-4-thiazolyl)-methyl)thio)-N'-(a minosulfonyl) propanimidamide], also known as YM-11170… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)